Short answer · Medically reviewed summary · Last updated: 2026-04-07
Antithrombin III deficiency, also referred to as hereditary antithrombin deficiency, is a rare blood disorder characterized by a reduced level or impaired function of the antithrombin protein, which significantly increases the risk of venous thromboembolism. Because this condition has been studied for decades, it is often documented under various synonyms including antithrombin deficiency, ATIII deficiency, and hereditary antithrombin III deficiency. What are the common names and synonyms for Antithrombin III deficiency? In medical literature and clinical settings, you will encounter several names for Antithrombin III deficiency.
Antithrombin III deficiency, also referred to as hereditary antithrombin deficiency, is a rare blood disorder characterized by a reduced level or impaired function of the antithrombin protein, which significantly increases the risk of venous thromboembolism. Because this condition has been studied for decades, it is often documented under various synonyms including antithrombin deficiency, ATIII deficiency, and hereditary antithrombin III deficiency.
In medical literature and clinical settings, you will encounter several names for Antithrombin III deficiency. While "Antithrombin III deficiency" remains the most common term used in legacy medical records, modern hematology often shortens this to "Antithrombin deficiency." This shift reflects the fact that the protein is now formally recognized simply as "antithrombin" (AT), as the Roman numeral "III" was historically used to distinguish it from other clotting factors that were later reclassified. Other synonyms you may find include hereditary antithrombin deficiency and familial antithrombin deficiency. Abbreviations commonly used in clinical notes include ATIII deficiency, AT-III deficiency, or simply AT deficiency.
The variety of names for Antithrombin III deficiency stems from both historical nomenclature and evolving scientific understanding. When the protein was first identified, it was labeled with the Roman numeral "III" to distinguish it from other plasma proteins. As biochemical research progressed, scientists determined that this protein is the primary physiological inhibitor of thrombin and other coagulation factors. Consequently, many international organizations have moved toward the name "Antithrombin" to simplify terminology. Older medical journals and textbooks will almost exclusively use "Antithrombin III deficiency," while current clinical guidelines are shifting toward "Antithrombin deficiency" to align with modern protein nomenclature.
For patients navigating medical records or insurance documentation, it is helpful to know how Antithrombin III deficiency is categorized in authoritative global systems:
While "Antithrombin deficiency" is the preferred terminology in modern hematology, medical professionals are universally familiar with Antithrombin III deficiency. If you are discussing your diagnosis, using either term is acceptable, though you may want to clarify that you are referring to the hereditary form of the condition if applicable. At DiseaseMaps.org, where 42 community members have shared their experiences, you will see both terms used interchangeably. Regardless of the label, the clinical focus remains the same: managing the risk of thrombosis through appropriate anticoagulation strategies and monitoring.
Medical disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of a qualified healthcare provider with any questions regarding a medical condition.